back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-04-05 12:40 Tx date 2023-03-31 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Kovaleva, Tatiana
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,500
+150,000 vol $0.05 each |
150,000 | |
| Filed 2023-04-05 12:38 Tx date 2022-12-01 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Kovaleva, Tatiana
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-1,000,000 vol |
0 | |
| Filed 2023-04-05 12:35 Tx date 2023-03-31 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Stadnyk, Zachary Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$62,500
+1,250,000 vol $0.05 each |
1,250,000 | |
| Filed 2023-04-05 12:33 Tx date 2022-12-01 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Stadnyk, Zachary Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-11,000,000 vol |
0 | |
| Filed 2023-04-04 13:31 Tx date 2023-03-31 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Taylor, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,500
+250,000 vol $0.05 each |
250,000 | |
| Filed 2023-04-04 13:28 Tx date 2022-12-01 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Taylor, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-1,000,000 vol |
0 | |
| Filed 2023-03-31 16:10 Tx date 2023-03-31 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Tommasi, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2022-12-01 14:47 Tx date 2021-11-23 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Tommasi, Mark
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-25,000
-500,000 vol $0.05 each |
0 | |
| Filed 2022-08-29 17:28 Tx date 2021-11-23 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Kovaleva, Tatiana
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+500,000 vol $0.05 each |
500,000 | |
| Filed 2022-08-29 11:56 Tx date 2022-08-24 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Kovaleva, Tatiana
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+500,000 vol $0.05 each |
500,000 | |
| Filed 2022-08-29 11:54 Tx date 2018-06-27 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Kovaleva, Tatiana
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-08-29 11:53 Tx date 2022-08-24 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Taylor, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+500,000 vol $0.05 each |
1,000,000 | |
| Filed 2022-08-29 11:50 Tx date 2022-08-24 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Stadnyk, Zachary Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$250,000
+5,000,000 vol $0.05 each |
11,000,000 | |
| Filed 2022-08-25 10:40 Tx date 2022-08-24 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Stadnyk, Zachary Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$125,000
+2,500,000 vol $0.05 each |
5,250,000 | |
| Filed 2022-08-25 10:39 Tx date 2022-08-24 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Stadnyk, Zachary Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$35,000
+2,500,000 vol $0.014 each |
6,750,000 | |
| Filed 2022-08-25 10:35 Tx date 2022-08-24 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Taylor, Douglas
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+500,000 vol $0.05 each |
2,688,000 | |
| Filed 2022-08-25 10:34 Tx date 2022-08-24 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Taylor, Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$7,000
+500,000 vol $0.014 each |
2,688,000 | |
| Filed 2022-06-09 10:57 Tx date 2022-06-08 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Stadnyk, Zachary Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 8986207 Canada Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+4,500,000 vol |
5,000,000 | |
| Filed 2022-06-09 10:55 Tx date 2022-06-08 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Stadnyk, Zachary Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+2,750,000 vol |
2,750,000 | |
| Filed 2022-06-09 10:52 Tx date 2021-09-21 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Stadnyk, Zachary Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-09 10:52 Tx date 2022-06-08 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Stadnyk, Zachary Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 8986207 Canada Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$49,500
+4,500,000 vol $0.011 each |
5,000,000 | |
| Filed 2022-06-09 10:50 Tx date 2022-06-08 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Stadnyk, Zachary Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$30,250
+2,750,000 vol $0.011 each |
4,250,000 | |
| Filed 2021-11-26 10:21 Tx date 2021-11-23 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Taylor, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+500,000 vol $0.05 each |
500,000 | |
| Filed 2021-11-26 10:18 Tx date 2018-03-09 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Taylor, Douglas
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-25 17:26 Tx date 2021-11-23 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Tommasi, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
| Filed 2021-11-25 17:24 Tx date 2018-12-20 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Tommasi, Mark
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-24 14:52 Tx date 2021-11-23 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Stadnyk, Zachary Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$300,000
+6,000,000 vol $0.05 each |
6,000,000 | |
| Filed 2021-11-24 14:49 Tx date 2021-09-21 |
$LUV
Love Pharma Inc. (formerly Glenbriar Technologies Inc.) |
Stadnyk, Zachary Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|